Table 1. Baseline characteristics of the 32 patients.
| Control (n = 16) |
Experimental (n = 16) |
P-value | |
|---|---|---|---|
| Age (y) | 29.31 (9.48) | 30.63 (7.27) | 0.664 |
| Sex | |||
| Males | 11 (68.8) | 15 (93.8) | 0.172 |
| HLA mismatching | 0.325 | ||
| 1 | 8 (50.0) | 8 (50.0) | |
| 2 | 4 (25.0) | 7 (43.8) | |
| 3 | 4 (25.0) | 1 (6.2) | |
| eGFR (mL/min) | 5.29 (3.82) | 5.02 (2.19) | 0.812 |
| Scr (μmol/L) | 1215.19 (498.34) |
1208.50 (321.40) |
0.964 |
| Urea (mmol/L) | 23.93 (15.17, 36.56) |
20.94 (16.88, 25.31) |
0.468 |
| Urine protein (q/L)1 | 1.25 (1.00, 3.00) | 3.00 (2.00, 3.00) | 0.201 |
| Urinary RBC (count/μL)1 | 6.00 (2.00, 26.00) | 66.00 (5.00, 119.00) | 0.041* |
| Urinary WBC (count/μL)1 | 8.00 (3.00, 38.00) | 11.00 (4.00, 23.00) | 0.747 |
| Percentage of LN (%) | 25.86 (5.83) | 23.17 (6.44) | 0.225 |
| LN count (109/L) | 1.58 (0.42) | 1.42 (0.36) | 0.269 |
| CD19 (%) | 12.32 (4.62) | 11.12 (5.16) | 0.494 |
| CD3 (%) | 73.66 (9.09) | 71.01 (10.91) | 0.462 |
| CD34 (%) | 39.77 (8.01) | 41.27 (8.39) | 0.609 |
| CD38 (%)1 | 30.94 (9.38) | 26.73 (7.28) | 0.172 |
| NK (%) | 7.20 (6.00, 10.67) | 7 (5.04, 8.37) | 0.445 |
| Follow-up duration (months) | 23.87 (18.68, 33.03) | 30.07 (19.68, 33.50) | 0.468 |
| Age of donors | 45.56 (12.98) | 50.56 (6.85) | 0.183 |
| Male gender of donors | 8 (50.0%) | 5 (31.3%) | 0.473 |
| Creatinine of donors | 71.06 (8.96) | 77.69 (9.97) | 0.057 |
eGFR, estimated glomerular filtration rate; Scr, serum creatinine; RBC, red blood cell; WBC, white blood cell; LN, lymphocytes; NK, natural killer
Continuous data were presented as mean (standard deviation) or median (interquartile range) and tested by the independent t-test or Mann-Whitney U test.
HLA mismatching was expressed as n (%) and tested by Fisher's exact test.
*
Indicates significant difference between the two groups, P <0.05.
1
Some missing data were found.